Amgen | AMGN - Capitalização De Mercado

Preço das Ações
347.49
Mudança Diária
9.47 2.80%
Mensal
-1.24%
Anual
22.45%
Q2 Previsão
337.18




Capitalização De Mercado Alterar Data
AbbVie USD 360.74B 23.94B 2026-04
Agios Pharmaceuticals USD 1.6B 410M 2026-04
ALKERMES USD 4.62B 333M 2025-12
Amgen USD 187.49B 11.24B 2026-04
Biogen USD 28.34B 1.44B 2026-04
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Bristol-Myers Squibb USD 122.54B 1.29B 2026-04
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 882.91B 13.89B 2026-04
Exelixis USD 11.75B 959M 2025-12
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
GlaxoSmithKline GBP 80.41B 3.39B 2026-04
Glaxosmithkline GBP 99.93B 13.05B 2025-12
Incyte USD 21.96B 3.23B 2026-04
Ionis Pharmaceuticals USD 10.9B 1.55B 2026-04
J&J USD 561.65B 17.5B 2026-04
Merck USD 279.96B 18.7B 2026-04
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 231.75B 76B 2026-04
Novartis USD 263.08B 17.01B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 5.26B 844M 2026-04
Regeneron Pharmaceuticals USD 75.34B 6.35B 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
Sarepta Therapeutics USD 2.26B 238M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Teva Pharmaceutical Industries USD 116.7B 82.42B 2026-04
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12